D-0990-2019 Class III Terminated

Recalled by AVKARE Inc. — Pulaski, TN

FDA drug recall D-0990-2019 was initiated by AVKARE Inc. on Mar 1, 2019 and is designated Class III. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Jan 14, 2020). Affected quantity: a) 2947 and b) 3379.

Recall details

Product Type
Drugs
Report Date
Mar 20, 2019
Initiation Date
Mar 1, 2019
Termination Date
Jan 14, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 2947 and b) 3379

Product description

Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (NDC 42291-634-50) bottles, Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide.

Code information

Lots: a) 22738 Exp. 07/2020 and b) 22739 Exp. 07/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0990-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0990-2019. Report a data issue: hello@regdatalab.com.